Literature DB >> 30146797

Self-Assembly of Immune Signals Improves Codelivery to Antigen Presenting Cells and Accelerates Signal Internalization, Processing Kinetics, and Immune Activation.

Michelle L Bookstaver1, Krystina L Hess1, Christopher M Jewell1,2,3,4,5.   

Abstract

Vaccines and immunotherapies that elicit specific types of immune responses offer transformative potential to tackle disease. The mechanisms governing the processing of immune signals-events that determine the type of response generated-are incredibly complex. Understanding these processes would inform more rational vaccine design by linking carrier properties, processing mechanisms, and relevant timescales to specific impacts on immune response. This goal is pursued using nanostructured materials-termed immune polyelectrolyte multilayers-built entirely from antigens and stimulatory toll-like receptors agonists (TLRas). This simplicity allows isolation and quantification of the rates and mechanisms of intracellular signal processing, and the link to activation of distinct immune pathways. Each vaccine component is internalized in a colocalized manner through energy-dependent caveolae-mediated endocytosis. This process results in trafficking through endosome/lysosome pathways and stimulation of TLRs expressed on endosomes/lysosomes. The maximum rates for these events occur within 4 h, but are detectable in minutes, ultimately driving downstream proimmune functions. Interestingly, these uptake, processing, and activation kinetics are significantly faster for TLRas in particulate form compared with free TLRa. Our findings provide insight into specific mechanisms by which particulate vaccines enhance initiation of immune response, and highlight quantitative strategies to assess other carrier technologies.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  immunotherapy; nanotechnology; rational design; self-assembly; vaccine

Mesh:

Substances:

Year:  2018        PMID: 30146797      PMCID: PMC6252008          DOI: 10.1002/smll.201802202

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  45 in total

Review 1.  Polymeric multilayer capsules for drug delivery.

Authors:  Stefaan De Koker; Richard Hoogenboom; Bruno G De Geest
Journal:  Chem Soc Rev       Date:  2012-01-26       Impact factor: 54.564

2.  Surface-engineered polyelectrolyte multilayer capsules: synthetic vaccines mimicking microbial structure and function.

Authors:  Bruno G De Geest; Monique A Willart; Bart N Lambrecht; Charlotte Pollard; Chris Vervaet; Jean Paul Remon; Johan Grooten; Stefaan De Koker
Journal:  Angew Chem Int Ed Engl       Date:  2012-03-12       Impact factor: 15.336

Review 3.  Toll-like receptors: Activation, signalling and transcriptional modulation.

Authors:  Dominic De Nardo
Journal:  Cytokine       Date:  2015-04-03       Impact factor: 3.861

Review 4.  Cell-penetrating peptides: design, synthesis, and applications.

Authors:  Dana Maria Copolovici; Kent Langel; Elo Eriste; Ülo Langel
Journal:  ACS Nano       Date:  2014-02-28       Impact factor: 15.881

Review 5.  Designing natural and synthetic immune tissues.

Authors:  Emily A Gosselin; Haleigh B Eppler; Jonathan S Bromberg; Christopher M Jewell
Journal:  Nat Mater       Date:  2018-05-21       Impact factor: 43.841

Review 6.  Communicating the role and value of vaccine adjuvants.

Authors:  Bruce G Gellin; David M Salisbury
Journal:  Vaccine       Date:  2015-06-08       Impact factor: 3.641

7.  Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.

Authors:  Takeshi Ichinohe; Izumi Watanabe; Satoshi Ito; Hideki Fujii; Masami Moriyama; Shin-Ichi Tamura; Hidehiro Takahashi; Hirofumi Sawa; Joe Chiba; Takeshi Kurata; Tetsutaro Sata; Hideki Hasegawa
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

8.  Subcellular localization of Toll-like receptor 3 in human dendritic cells.

Authors:  Misako Matsumoto; Kenji Funami; Masako Tanabe; Hiroyuki Oshiumi; Masashi Shingai; Yoshiyuki Seto; Akitsugu Yamamoto; Tsukasa Seya
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

Review 9.  Multilayered polyelectrolyte assemblies as platforms for the delivery of DNA and other nucleic acid-based therapeutics.

Authors:  Christopher M Jewell; David M Lynn
Journal:  Adv Drug Deliv Rev       Date:  2008-03-04       Impact factor: 15.470

10.  Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses.

Authors:  James J Moon; Heikyung Suh; Anna Bershteyn; Matthias T Stephan; Haipeng Liu; Bonnie Huang; Mashaal Sohail; Samantha Luo; Soong Ho Um; Htet Khant; Jessica T Goodwin; Jenelyn Ramos; Wah Chiu; Darrell J Irvine
Journal:  Nat Mater       Date:  2011-02-20       Impact factor: 43.841

View more
  6 in total

1.  Self-Assembly as a Molecular Strategy to Improve Immunotherapy.

Authors:  Eugene Froimchuk; Sean T Carey; Camilla Edwards; Christopher M Jewell
Journal:  Acc Chem Res       Date:  2020-10-19       Impact factor: 22.384

2.  Engineering release kinetics with polyelectrolyte multilayers to modulate TLR signaling and promote immune tolerance.

Authors:  Lisa H Tostanoski; Haleigh B Eppler; Boyan Xia; Xiangbin Zeng; Christopher M Jewell
Journal:  Biomater Sci       Date:  2019-02-26       Impact factor: 6.843

3.  Prussian blue nanoparticle-based antigenicity and adjuvanticity trigger robust antitumor immune responses against neuroblastoma.

Authors:  Juliana Cano-Mejia; Michelle L Bookstaver; Elizabeth E Sweeney; Christopher M Jewell; Rohan Fernandes
Journal:  Biomater Sci       Date:  2019-04-23       Impact factor: 6.843

Review 4.  Engineering Immune Tolerance with Biomaterials.

Authors:  Joshua M Gammon; Christopher M Jewell
Journal:  Adv Healthc Mater       Date:  2019-01-03       Impact factor: 9.933

Review 5.  Phage display as a tool for vaccine and immunotherapy development.

Authors:  Krystina L Hess; Christopher M Jewell
Journal:  Bioeng Transl Med       Date:  2019-09-18

6.  Altering Antigen Charge to Control Self-Assembly and Processing of Immune Signals During Cancer Vaccination.

Authors:  Shannon J Tsai; Allie Amerman; Christopher M Jewell
Journal:  Front Immunol       Date:  2021-01-06       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.